See also this year's filing and all EDGAR filings for this company.
PDF Report 0000887247_2012_DMK_Pharmaceuticals_Corp.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Expenses', 'value': 4815202, 'size_variable': 'Assets', 'size_value': 169039, 'ratio': 28.5, 'threshold': 20} |
Graph
Absolute values for 0000887247, DMK Pharmaceuticals Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,533,608 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 200,000 |
| 4 | LiabilitiesCurrent | 3,113,274 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,365,198 |
| 9 | ResearchAndDevelopmentExpense | 2,875,884 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -738,731 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,733,608 |
| 1 | Liabilities | 3,113,274 |
| 2 | Expenses | 6,241,082 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -1,379,666 |
| 5 | NetIncome | -6,979,813 |
| 6 | ComprehensiveNetIncome | -6,979,813 |
| 7 | BaseVar | 5,913,348 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.12 |
| 9 | EconomicCapitalRatio | 0.362 |
Edgar->Model Mapping
Feature Distribution
